
Aisling Ryan
Breathwork
Dublin, IE
The use of psychoactive substances including alcohol, cannabis, tobacco, opioids, or stimulants — ranging from low-risk to harmful use or dependence.
Quick answer
Substance use describes the consumption of psychoactive substances — including alcohol, tobacco, cannabis, opioids, stimulants, or other drugs — which may range from low-risk recreational use to harmful use or dependence. ICD-10: F10–F19 (mental and behavioural disorders due to psychoactive substances); ICD-11: 6C40–6C4Z. Requires contextual assessment across a spectrum from use to disorder.
Recognition
People often report using substances to escape reality or cope with emotions.
What is Substance Use?
The use of psychoactive substances including alcohol, cannabis, tobacco, opioids, or stimulants — ranging from low-risk to harmful use or dependence.
Commonly explored for conditions related to Substance Use, grouped by mechanism — select your subtype above to highlight the most relevant path.
How to use these approaches
Most people begin with Stabilise approaches, then progress toward Resolve and Sustain.
Cognitive patterns, emotional processing, and stress response.
Not sure what this means for you?
Ask Vidi to help you understand Substance Use and find what may be most relevant for your situation.
Ranked by experience and relevance to Substance Use.
Connect with holistic and complementary practitioners who specialise in this area.
Find support tailored to your experienceSelf-care
Self-directed strategies that may support Substance Use alongside professional care.
Connections
Substance Use commonly appears alongside or as part of these conditions.
Vidi · AI guide
Explore what may be associated with Substance Use, supportive approaches, and questions to ask a practitioner.
Gyfts is educational and cannot diagnose or replace care from a qualified professional.
Substance use spans a spectrum from occasional, low-risk use to harmful use (causing health, social, or occupational harm without dependence) to substance use disorder (characterised by compulsive use, tolerance, withdrawal, and loss of control). Commonly used substances include alcohol, tobacco/nicotine, cannabis, opioids (prescription and illicit), stimulants (cocaine, amphetamines, MDMA), sedatives (benzodiazepines), and psychedelics. Substance use is associated with a broad range of physical and mental health consequences depending on substance, route of administration, frequency, and individual vulnerability. Polysubstance use (use of multiple substances) is common and increases risk complexity. Social, economic, trauma, and genetic factors all influence use patterns. Harm reduction — reducing risks without requiring abstinence — is an evidence-based public health approach.
Research & traditional use overview
NICE and WHO guidelines recommend screening (AUDIT for alcohol, DAST for other drugs), brief intervention, and referral to treatment (SBIRT model). Pharmacological treatments include NRT and varenicline (nicotine), methadone/buprenorphine (opioids), naltrexone and acamprosate (alcohol), and bupropion (stimulants — limited evidence). Psychological treatments with strong evidence include motivational interviewing, CBT, contingency management, and 12-step facilitation. Harm reduction interventions (naloxone access, needle exchanges, supervised consumption) reduce mortality. The FRAMES framework (Feedback, Responsibility, Advice, Menu, Empathy, Self-efficacy) guides effective brief intervention.
Evidence varies by person and approach. People explore these options for support; professional guidance may be appropriate.
Safety
Seek doctor or addiction specialist assessment for any substance use causing concern — regardless of whether full dependence criteria are met. Seek urgent medical assessment for withdrawal from alcohol, benzodiazepines, or opioids — all carry significant physical risks. Harm reduction services, drug and alcohol teams, and peer support programmes are widely available.
Questions